Bassett, David B.

David B. Bassett

Bassett, David B.

David B. Bassett

Partner

  • Chair, Associates Committee

David Bassett's practice concentrates on intellectual property litigation, particularly on biotechnology, pharmaceutical and Hatch-Waxman patent disputes. He also represents clients in a wide variety of other business disputes, including breach of contract, Lanham Act and Internet-related claims. Mr. Bassett's intellectual property litigation clients have included Forest (Allergan), Gilead Sciences, Foundation Medicine, Precision BioSciences, Biogen, Procter & Gamble, Calgene, Cephalon, Kurzweil Music, RSA Security, Braintree Laboratories and many others. His practice has covered all facets of litigation, including discovery, settlement, alternative dispute resolution, trials and appeals. Mr. Bassett has been lead trial lawyer in more than a dozen patent trials (both bench and jury), and has appeared before the Courts of Appeals for the First and Federal Circuits.

Mr. Bassett is a partner in the firm's Litigation/Controversy Department, a member of the Intellectual Property Litigation Practice and FinTech Group. He is the former chair of the firm's Associates Committee and of the firm's Intellectual Property Practice. He joined the firm in 1989.

Community Involvement

  • Former Chair, Masconomet Regional School Committee

Professional Activities

  • Executive Committee of the New York State Bar Association, Intellectual Property Law Section
  • Member, American Bar Association
  • Member, Massachusetts Bar Association

Experience

  • During the last several years, Mr. Bassett has handled cases for numerous clients, including:

    • A successful jury trial for a biotechnology company that developed an innovative genome editing method
    • Representing a large pharmaceutical company dealing with multiple generic challenges to its flagship HIV treatment patents
    • Counseling the leading company in comprehensive genomic profiling of cancer-related genes
    • Handling multiple inter partes reviews for one of the country's largest plastics company
    • Representing a major biotechnology company in one of the largest biotech patent litigations in the country
    • Representing a leading biopharmaceutical company in a series of patent and patent licensing litigations
    • Representing an integrated business consulting service company in litigation to enforce a noncompete agreement with a former employee

Recognition

  • Highly recommended as a leading lawyer in the IP industry in the 2017 edition of Patents Expert Guide
  • Recognized as a New York leader in the Intellectual Property: Patent field in the 2005-2008 and 2010-2013 editions of Chambers USA: America's Leading Lawyers for Business
  • Named a "Life Sciences Star" in the 2012-2017 editions of LMG Life Sciences
  • Named a 2014 and 2015 leading practitioner in patent law by IAM Patent 1000: The World's Leading Patent Practitioners
  • Selected as a "New York Super Lawyer" from 2009 through 2017 for his intellectual property litigation practice
  • Highly recommended in the PLC Cross-border IP in Business Transactions Handbook 2008/09
  • Recognized as one of the world's leading life sciences - patent litigation lawyers in the 2008, 2010, 2011 and 2016 editions of Who's Who Legal: The International Who's Who of Life Sciences Lawyers
  • Selected as a "patent law expert" in Legal Media Group's Guide to the World's Leading Patent Law Practitioners 2007
  • Recommended in the 2006-07 edition of the PLC IP & IT Cross-Border Handbook
  • Named a "New England Super Lawyer" (formerly "Massachusetts Super Lawyer") in intellectual property litigation in the 2004, 2005, 2006 and 2007 issues of Boston Magazine

Insights & News

Credentials